Novo Nordisk A/S: Diferență între versiuni

De la TradeVille.ro wiki
(Pagină nouă: Pagina dedicata companiei Novo Nordisk A/S listata cu simbolurile DK.NOVOb.D, US.NVO ==Descriere companie== Novo Nordisk A/S (https://www.novonordisk.com/) is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment...)
 
Fără descriere a modificării
 
(Nu s-a afișat o versiune intermediară efectuată de un alt utilizator)
Linia 1: Linia 1:
Pagina dedicata companiei Novo Nordisk A/S listata cu simbolurile DK.NOVOb.D, US.NVO
Pagina dedicata companiei Novo Nordisk A/S listata cu simbolul US.NVO


==Descriere companie==
==Descriere companie==
Linia 5: Linia 5:


==Grafic actiuni companie==
==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/DK.NOVOb.D" />
<div class="link2buy">
[https://app.tradeville.ro/s?US.NVO Tranzactioneaza]
</div>
<iframe key="tradeville" path="graficSimbol/US.NVO" />
<iframe key="tradeville" path="graficSimbol/US.NVO" />


==Ultimele stiri despre Novo Nordisk A/S (DK.NOVOb.D)==
<dynamicpagelist>
category=DK.NOVOb.D
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>
==Ultimele stiri despre Novo Nordisk A/S (US.NVO)==
==Ultimele stiri despre Novo Nordisk A/S (US.NVO)==
<dynamicpagelist>
<dynamicpagelist>
Linia 23: Linia 18:
</dynamicpagelist>
</dynamicpagelist>


[[Categorie:DK.NOVOb.D]][[Categorie:US.NVO]][[Categorie:Stiri despre companii]]
[[Categorie:US.NVO]][[Categorie:Stiri despre companii]]

Versiunea curentă din 31 octombrie 2024 17:31

Pagina dedicata companiei Novo Nordisk A/S listata cu simbolul US.NVO

Descriere companie[edit | ]

Novo Nordisk A/S (https://www.novonordisk.com/) is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Grafic actiuni companie[edit | ]

Tranzactioneaza

Ultimele stiri despre Novo Nordisk A/S (US.NVO)[edit | ]

Adus de la „https://wiki.tradeville.ro/index.php?title=Novo_Nordisk_A/S&oldid=454283”